Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma.
Kars A, Celik I, Kansu E, Tekuzman G, Ozişik Y, Güler N, Barişta I, Güllü I, Yalçin S, Altundağ K, Zengin N, Türker A, Hayran M, Baltali E, Firat D.
Kars A, et al. Among authors: zengin n.
Eur J Haematol. 1997 Aug;59(2):100-4. doi: 10.1111/j.1600-0609.1997.tb00732.x.
Eur J Haematol. 1997.
PMID: 9293857
Clinical Trial.